Growth opportunity Apollo Endosurgery operates in a niche medical device space focused on less invasive endoscopic solutions for GI conditions with products sold in over 75 countries; potential upsell opportunities exist with expanded adoption of the OverStitch, X-Tack, and ORBERA systems across additional international markets and hospital networks.

New leadership transition Recent CEO departure signals potential for strategic realignment and renewed sales initiatives; leverage this window to introduce value-focused partnerships, address customer pain points, and position complementary devices to support a refreshed growth agenda.

Revenue scale Current revenue range of 10–25 million with moderate funding of 30 million suggests a growth-stage profile; target hospitals and ambulatory surgery centers with volume potential for endoscopic suturing and intragastric balloon programs to accelerate top-line expansion.

Global footprint Established international footprint across 75+ countries offers cross-border expansion play; identify regional distributors and key GI centers where adoption of OverStitch and related systems can reduce surgical referrals and enhance patient outcomes.

Tech and compliance Tech stack includes cloud, analytics, and compliance tools; collaborate on data-driven outcomes demonstrations, regulatory-ready sales materials, and patient safety case studies to build trust with procurement and clinical teams.